Pre-clinical development of Corallopyronin A – a natural product active against helminths, STIs and Staphylococci

IMMIP scientists working on drug development presented the latest results on the pre-clinical development of corallopyronin A at the AMR Conference 2023 in Basel, Switzerland (https://amr-conference.com/programme-2023/), hosted by the BEAM Alliance. There they met with representatives from iiCON, Infex Therapeutics and INCATE to discuss strategies to bring corallopyronin A to registration.

Conference Poster

Dr. Andrea Schiefer presenting the poster in Basel